Articles
15.12.2021
Patent protection in the pharmaceutical industry

Patent cliff refers to a sharp decline in revenue or profitability when a firm’s patents expire, o...

Read more
Articles
13.12.2021
Global market access team

This educational blog will explore what a GMA team does strategically and operationally across the l...

Read more
Articles
07.12.2021
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
03.12.2021
Reflecting on the Pricing & Market Access tren...

Our experts reflect on the pricing and market access trends that shaped the European Landscape in 20...

Read more
Publications
03.12.2021
Highly specialised technologies process

Is the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...

Read more
Publications
03.12.2021
Orphan drug status benefit

The purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.

Read more
News
27.11.2021
PMA Insights: Week 43

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
News
24.11.2021
PMA Insights: Week 47 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
22.11.2021
NICE cost effective medicines

When making a decision about the approval of a new product NICE (National Institute for Health and C...

Read more
Articles
17.11.2021
Head of agencies HAG

The Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.